Abstract
This work was supported by National Institute on Aging Grants P01 AG03991 and P50 AG05681. Disclosure: Neither Dr. Morris nor his family owns stock or has equity interest (outside of mutual funds or other externally directed accounts) in any pharmaceutical or biotechnology company. Since July 2003, Dr. Morris participated or is currently participating in clinical trials of anti-dementia drugs sponsored by Elan, Eli Lilly and Company, Merck, and Wyeth. In 2003 and 2004, Dr. Morris served as a consultant for or received speaking honoraria from the following companies: Amgen, Axonyx, BristolMyersSquibb, Codman-Johnson & Johnson, Eisai, Elan, Forest Labs, Neurochem, Novartis, Sanofi-Aventis, and Shionogi-Glaxo-Smith-Kline. Reprints: John C. Morris, MD, Friedman Distinguished Professor of Neurology Alzheimer's Disease Research Center, Washington University, 4488 Forest Park, Suite 130, St. Louis, MO 63108 (e-mail: [email protected]).
Keywords
DementiaGerontologyMedicineManagementFamily medicineLibrary sciencePsychologyDiseaseInternal medicineComputer science
Related Publications
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Abstract In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the preclinical, mild cognitive impairment, and dem...
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, ad...
Publication Info
- Year
- 2005
- Type
- article
- Volume
- 19
- Issue
- 3
- Pages
- 163-165
- Citations
- 188
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
188
OpenAlex
Cite This
NULL AUTHOR_ID
(2005).
Early-Stage and Preclinical Alzheimer Disease.
Alzheimer Disease & Associated Disorders
, 19
(3)
, 163-165.
https://doi.org/10.1097/01.wad.0000184005.22611.cc
Identifiers
- DOI
- 10.1097/01.wad.0000184005.22611.cc